Explore CSPG4/NG2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008]
| Target ID |
GM-T38041
|
| Target Name |
CSPG4/NG2
|
Gene Group ldentifer
（Target Gene ID in Homo
species)
|
1464
|
| Gene ID |
100061543 (Equus caballus), 101097242 (Felis catus), 121021 (Mus musculus), 1464 (Homo sapiens)
487658 (Canis lupus familiaris), 533653 (Bos taurus), 713086 (Macaca mulatta), 81651 (Rattus norvegicus)
|
| Target Alternative Names |
4732461B14Rik,AN2,CSPG4,CSPG4A,Chondroitin sulfate proteoglycan 4,Chondroitin sulfate proteoglycan NG2,Cspg4,Cspg4a,HMW-MAA,MCSP,MCSPG,MEL-CSPG,MSK16,Melanoma chondroitin sulfate proteoglycan,Melanoma-associated chondroitin sulfate proteoglycan,NG2,Ng2
|
| Uniprot Accession |
Q8VHY0,Q6UVK1,Q00657
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, Immuno-oncology Target
|
| Disease |
Prostate Cancer
|
| Gene Ensembl |
ENSECAG00000010692, ENSMUSG00000032911, ENSG00000173546, ENSCAFG00845020860, ENSBTAG00000012219, ENSMMUG00000016104
|
| Target Classification |
Checkpoint-Immuno Oncology
|
CSPG4/NG2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo1464 | Pre-made Human CSPG4/NG2/MCSP siRNA oligo Duplex | 1464 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo81651 | Pre-made Rat Cspg4/Ng2 siRNA oligo Duplex | 81651 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo121021 | Pre-made Mouse Cspg4/AN2/NG2 siRNA oligo Duplex | 121021 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo713086 | Pre-made Cynomolgus/Rhesus macaque CSPG4 siRNA oligo Duplex | 713086 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101097242 | Pre-made Cat/Feline CSPG4 siRNA oligo Duplex | 101097242 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo487658 | Pre-made Dog/Canine CSPG4 siRNA oligo Duplex | 487658 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo533653 | Pre-made Bovines/Cattle CSPG4 siRNA oligo Duplex | 533653 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100061543 | Pre-made Equine/Horse CSPG4 siRNA oligo Duplex | 100061543 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CSPG4/NG2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T38041-Ab | Human | Anti-Human CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T38041-Ab | Rat | Anti-Rat CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T38041-Ab | Mouse | Anti-Mouse CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T38041-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T38041-Ab | Cat/Feline | Anti-Cat/Feline CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T38041-Ab | Dog/Canine | Anti-Dog/Canine CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T38041-Ab | Bovines/Cattle | Anti-Bovines/Cattle CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T38041-Ab | Equine/Horse | Anti-Equine/Horse CSPG4/NG2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CSPG4/NG2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T38041-Ag | Human | Human CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T38041-Ag | Rat | Rat CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T38041-Ag | Mouse | Mouse CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T38041-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T38041-Ag | Cat/Feline | Cat/Feline CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T38041-Ag | Dog/Canine | Dog/Canine CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T38041-Ag | Bovines/Cattle | Bovines/Cattle CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T38041-Ag | Equine/Horse | Equine/Horse CSPG4/NG2 VLP (virus-like particle) | HEK293 | Products Developing |
